low-dose dexamethasone

DRUG2 trials

Sponsors

Celgene, London Health Sciences Centre

Conditions

Multiple MyelomaMultiple Myeloma in RelapseRefractory Multiple MyelomaTonsillitis

Phase 1

Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma

CompletedNCT02103335

CelgeneMultiple Myeloma, Multiple Myeloma in Relapse, Refractory Multiple Myeloma

Start: 2014-06-05End: 2016-11-30Updated: 2017-11-22

Phase 4

Perioperative Tonsillectomy Protocol Development

London Health Sciences CentreTonsillitis

Start: 2018-03-01End: 2021-09-30Target: 60Updated: 2021-02-18